Rachel Brightwell, MD
Gynecologic Oncology · Lawrenceville, GANPI 1619207040
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for gynecologic oncology clinicians in GA, where the typical reported total is $3,080.
Across 124 payments — averaging $24.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$412
- Johnson & Johnson$315
- GSK$217
- Seagen Inc.$212
- Astellas Pharma US Inc$204
- Amgen$184
- plus $2K from 35 others
What the payments were for
- Food & beverage$2,80891%
- Education$2799%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 22 | $412 |
| Johnson & Johnson(2 entities) | 11 | $315 |
| GSK | 4 | $217 |
| Seagen Inc. | 7 | $212 |
| Astellas Pharma US Inc | 4 | $204 |
| Amgen | 8 | $184 |
| Baxter Healthcare | 2 | $140 |
| Caris MPI, Inc. | 2 | $124 |
| Novartis | 6 | $123 |
| Tersera Therapeutics LLC | 3 | $93 |
| Pfizer | 4 | $81 |
| Sanofi-aventis U.S. LLC | 1 | $78 |
| AstraZeneca | 4 | $75 |
| Morphosys, US Inc. | 3 | $70 |
| AbbVie | 3 | $65 |
| Eisai Inc. | 4 | $64 |
| Sanofi | 3 | $53 |
| Taiho Oncology, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Davol Inc. | 1 | $40 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Organon | 3 | $33 |
| Incyte Corporation | 2 | $33 |
| Pharmacosmos Therapeutics Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Gilead | 1 | $25 |
| Immunomedics, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Verastem, Inc. | 1 | $22 |
| EUSA Pharma (US) LLC | 1 | $22 |
| Vertex | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $16 |
| Acrotech Biopharma Inc. | 1 | $15 |
| Array Biopharma Inc | 1 | $15 |
| Clovis Oncology, Inc. | 2 | $14 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Octapharma USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$129
- PerClot$126
- ZEJULA$125
- MI CANCER SEEK$101
How this compares
$3,087 in reported general payments places this provider in the 50th percentile of 49 gynecologic oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 15 | $83 |
| Tramadol Hcl | 20 | $31 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Lawrenceville
- Stephen SalmieriLawrenceville$5K
- Matthew BurrellLawrenceville$107
- James BurkeSavannah$276K
- Benedict BenignoAtlanta$273K
- Sharad GhamandeAugusta$214K
- Ruchi GargNewnan$125K
- Adam PyrzakAtlanta$116K
- Gerald FeuerAtlanta$102K
- Margarett EllisonMoultrie$81K
- Vijaya GalicGainesville$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.